$ANIK Recent News Two names for a two-way stock market

New Post Public Reply Private Reply Replies (0) Message Board

May 15, 2014 at 11:58 AM

$ANIK Recent News

Two names for a two-way stock market 2:42 p.m. May 8, 2014 - The Trading Deck
Nasdaq treads water while a few names show their stuff 2:36 p.m. May 6, 2014 - The Trading Deck
Dow edges to less-charted technical territory 11:48 a.m. May 1, 2014 - Michael Ashbaugh
Dow edges to less-charted territory 11:27 a.m. May 1, 2014 - Michael Ashbaugh
S&P 500 extends the break to ‘clear skies’ territory 11:46 a.m. March 6, 2014 - Michael Ashbaugh
Stock futures edge higher ahead of home sales 9:11 a.m. Feb. 26, 2014 - William L. Watts
First Solar shares burned as earnings disappoint 7:05 p.m. Feb. 25, 2014 - Wallace Witkowski
Amgen boosts biotech sector to close up 6:23 p.m. March 11, 2011 - Wallace Witkowski
Human Genome rallies against biotech downturn 6:04 p.m. March 10, 2011 - Wallace Witkowski
Illumina dives, Anika rallies on earnings reports 11:53 a.m. Oct. 28, 2009 - Val Brickates Kennedy
Genzyme, Merck lead as drug stocks move higher 1:04 p.m. Aug. 21, 2009 - Val Brickates Kennedy
Thursday's biggest gaining and declining stocks 5:07 p.m. Aug. 20, 2009 - MarketWatch
Drug stocks gain; Anika zooms on drug approval 12:32 p.m. Aug. 20, 2009 - Val Brickates Kennedy
Wednesday's biggest stock gainers and decliners 5:27 p.m. July 25, 2007 - Gabriel Madway
Stocks in focus for Wednesday 7:37 p.m. July 24, 2007 - MarketWatch
Friday's biggest stock gainers and decliners 4:42 p.m. April 13, 2007 - Michael Baron
Stocks in focus Friday 7:14 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics receives CE Mark approval for Elevess 5:30 p.m. April 12, 2007 - Katherine Hunt
Anika Therapeutics up 5.3% at $14.10 10:46 a.m. Dec. 21, 2006 - Tomi Kilgore
Anika Thera gets FDA approval for cosmetic tissue augment 9:52 a.m. Dec. 21, 2006 - Thomas Middleton

IBD 50 High-Growth Shares Remain In Correction 5:55 p.m. May 9, 2014 - Investors Business Daily
Focus On Anika Therapeutics 6:09 a.m. May 8, 2014 - Seeking Alpha
10-Q: ANIKA THERAPEUTICS, INC. 5:30 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Insider Trading Alert - ANIK, TRLA And AMED Traded By Insiders 10:15 a.m. May 5, 2014 - TheStreet.com
Anika Therapeutics' CEO Discusses Q1 2014 Results - Earnings Call Transcript 4:04 p.m. April 30, 2014 - Seeking Alpha
Notable earnings after Tuesday’s close 5:35 p.m. April 28, 2014 - Seeking Alpha
Some IBD 50 Stocks May Be Forming Bases 5:42 p.m. April 25, 2014 - Investors Business Daily
Facebook, Arris, Grifols Initiate New Bases 5:35 p.m. April 11, 2014 - Investors Business Daily
Biotech IPOs Adamas, Cerulean Slump In Trading Debut 3:02 p.m. April 10, 2014 - Investors Business Daily
PolyOne, Anika, Methode Among The Leading Small Caps 7:02 a.m. April 10, 2014 - Investors Business Daily
Biotechs, Medicals Get Hurt Amid Price-Inquiry News 5:26 p.m. March 21, 2014 - Investors Business Daily
10-K: ANIKA THERAPEUTICS INC 5:29 p.m. March 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Mutual Funds Loading Up On These 3 Top-Rated Stocks 7:02 a.m. March 7, 2014 - Investors Business Daily
Insider Trading Alert - SWK, ANIK And NYT Traded By Insiders 10:15 a.m. March 4, 2014 - TheStreet.com
Anika Therapeutics (ANIK) Showing Signs Of A Dead Cat Bounce Today 9:55 a.m. March 3, 2014 - TheStreet.com
Cramer's Mad Money - 10 Biggest Gains (2/27/14) 6:22 a.m. Feb. 28, 2014 - Seeking Alpha
Anika Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 1:43 p.m. Feb. 27, 2014 - Seeking Alpha
Anika Therapeutics (ANIK) In A Perilous Reversal 9:46 a.m. Feb. 27, 2014 - TheStreet.com
Mid-Day Market Update: First Solar Falls On Downbeat Results; Anika Therapeutics Shares Jump 11:52 a.m. Feb. 26, 2014 - benzinga.com
Anika Arthritis Drug Approval Sends Stock Soaring 10:47 a.m. Feb. 26, 2014 - Investors Business Daily

Biotech Companies Report Quarterly Financial Results - Analyst Notes on Intrexon, Acorda, Anika, Sangamo and Spectrum 9:30 a.m. May 14, 2014 - PR Newswire - PRF
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 6:32 p.m. May 7, 2014 - PR Newswire - PRF
Anika Therapeutics Reports First Quarter 2014 Financial Results 4:08 p.m. April 29, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Date of First-Quarter 2014 Financial Results Conference Call 5:09 p.m. April 16, 2014 - BusinessWire - BZX
Anika Therapeutics Announces First U.S. Commercial Sale of Monovisc® 2:31 p.m. April 15, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Dismissal of MONOVISC® U.S. Patent Infringement Lawsuit 8:55 a.m. March 13, 2014 - BusinessWire - BZX
Anika Therapeutics to Present at Canaccord Genuity Musculoskeletal Conference March 11 5:06 p.m. March 4, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 12:35 p.m. Feb. 27, 2014 - PR Newswire - PRF
Chesapeake Energy Falls after Missing Estimates; Anika Therapeutics Gets FDA Approval for Monovisc 2:16 a.m. Feb. 27, 2014 - ACCESSWIRE
Anika Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:06 p.m. Feb. 26, 2014 - BusinessWire - BZX
FDA Approves MONOVISC®, A New Single Injection Treatment for Treatment of Pain Due to Osteoarthritis of the Knee 5:00 p.m. Feb. 25, 2014 - BusinessWire - BZX
Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2013 Financial Results Conference Call 5:06 p.m. Feb. 12, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 11:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
Anika Therapeutics to Present at the Tenth Annual Noble Financial Equity Conference on January 20 5:40 p.m. Jan. 9, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 9:00 a.m. Dec. 24, 2013 - PR Newswire
Biotech Firms Participate in Upcoming Conferences; Sees Steady Numbers around Thanksgiving - Research Report on BioMarin, Halozyme, PDL BioPharma, Anika Therapeutics, and Exelis 9:00 a.m. Dec. 3, 2013 - PR Newswire
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics 9:00 a.m. Nov. 25, 2013 - PR Newswire
Allegion plc Set to Join the S&P 500; J.C. Penney to Join S&P MidCap 400; Aeropostle, Anika Therapeutics to Join S&P SmallCap 600 6:47 p.m. Nov. 22, 2013 - PR Newswire
Presentations, Executive Appointments, and Quarterly Financial Reports - Research Report on Jazz Pharmaceuticals, Insulet, The Cooper Companies, Anika Therapeutics, and Sangamo Biosciences 9:00 a.m. Nov. 6, 2013 - PR Newswire
Anika Therapeutics Reports 20% Total Revenue Growth and Record Third-Quarter Earnings 4:05 p.m. Oct. 30, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 245

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

MV Transportation Celebrates Leadership Nomination for FTA

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...